NIKTIMVO Market Size Analysis and Sales Forecast, 2034
NIKTIMVO in chronic graft‑versus‑host disease (cGvHD) and examines its potential development across idiopathic pulmonary fibrosis, cholangiocarcinoma, Hodgkin lymphoma, triple‑negative breast cancer and other solid tumors.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
- Scientists build cell line atlas of deadly cancers of the bile ducts and gallbladder
- Cholangiocarcinoma Workup: Laboratory Studies, Imaging Studies, Procedures
- New EASL Clinical Practice Guidelines on extrahepatic cholangiocarcinoma
- An open‑label study of pemigatinib in cholangiocarcinoma: final results from FIGHT‑202